DLEU2 participates in lymphovascular invasion and inhibits cervical cancer cell proliferation, migration, and invasion.

CONCLUSION: DLEU2 is involved in the pathology of cervical cancer, and it may be a target for clinical therapy.
PMID: 32922596 [PubMed]

Source: International Journal of Clinical and Experimental Pathology - September 15, 2020 Category: Pathology Authors: Zhang H, Wang X, Zhang Q, Ma Y, Wang Z Tags: Int J Clin Exp Pathol Source Type: research